chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SLOWING DOWN; ARM WEAKNESS; FEVER; FATIGUE; ARM TINGLING; PALE HANDS; HOT FLASHES; DROOPY EYES; LOW BLOOD PRESSURE; This spontaneous report received from a patient concerned a 34 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-APR-2021 13:30 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-APR-2021, the subject experienced arm tingling. On 07-APR-2021, the subject experienced pale hands. On 07-APR-2021, the subject experienced hot flashes. On 07-APR-2021, the subject experienced droopy eyes. On 07-APR-2021, the subject experienced low blood pressure. On 07-APR-2021, the subject experienced arm weakness. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced fatigue. On 07-APR-2021 20:30, the subject experienced slowing down. Laboratory data included: Body temperature (NR: not provided) 103.9 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm tingling on 07-APR-2021 19:30, and arm weakness, had not recovered from fever, fatigue, hot flashes, and droopy eyes, and the outcome of pale hands, low blood pressure and slowing down was not reported. This report was non-serious.
I did have a scratchy throat and my arm was itchy at injection site.  Next day I had a red spot and lump around injection site. I did develop a migraine the day after but can't conclusively say it was from the vaccine since I get them somewhat frequently
autism; Initial information received on 25-May-2022 regarding an unsolicited valid  serious case received from a consumer/non-hcp.  This case involves Child female patient who experienced autism while receiving vaccine diphtheria, tetanus and nos pertussis vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect diphtheria, tetanus and nos pertussis vaccine produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a serious autism (autism spectrum disorder) (unknown latency). This event was assessed as medically significant.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (autism).  At time of reporting, the outcome was Unknown for the event autism.; Sender's Comments: Sanofi Company Comment dated 30-MAY-2022: This case involves Child female patient who experienced autism while receiving vaccine diphtheria, tetanus and nos pertussis vaccine. Further information regarding concurrent condition during vaccination, previous vaccination, concomitant medication and tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the individual suspect vaccine cannot be assessed.
Product storage error; Expired vaccine administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (Product storage error) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). On 12-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) had resolved. At the time of the report, PRODUCT STORAGE ERROR (Product storage error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.   This case was linked to MOD-2021-285598 (Patient Link).
The second shot was on February 19. On February 20 and 21, patient experienced a sore arm and flu-like symptoms. On  Febuary 28, he had a stroke.  Hospital where the ambulance took him initially diagnosed it as Bells Palsy and prescribed prednisone and an anti-viral.  After an MRI the next day on Monday, he was diagnosed correctly as a stroke.  On Tuesday, he was airlifted to another hospital and was in the ICU for more than 2 days. Patient spent the next 7 days in the neuro-trauma step-down unit with the results of the debilitating stroke.  He is unable to swallow and his entire left side is affected as well as vision and hearing.
Body aches beginning with left back, progressing to full body over the next 1.5-2 hours.  Severe headache and dizziness.  Took naproxen (220 mg liquid gel capsule).   No symptoms noticed evening of vaccination, mild soreness at injection site at 5:30 am 5/2/2021 but no treatment sought.  Felt well enough to go for a hike (2 hours) and felt fine with no symptoms during or immediately after hike (activity concluded 8:15 am).
This is in follow-up to report(s) previously submitted on 8/14/2007. Initial and follow-up information has been received from a physician and a 21 year old female consumer who in the end of 20-JAN-2007, was vaccinated with the first dose of GARDASIL. There was no concomitant medication. Subsequently, the patient developed alopecia universalis. On 10-FEB-2007, "one week after receiving the first dose," 25 percent of the patient's hair fell out in clumps. It was reported that the hair she lost after the first dose had begun to grow back. In March 2007, the patient was vaccinated with the second dose of Gardasil. One week after receiving the second dose, "all her remaining hair fell out so that she was completely bald." Unspecific medical attention was sought. Laboratory tests performed included a "lupus test" (results not reported). It was reported that she will not be receiving the third dose. It was reported that the hair she lost after the second dose had not begun to grow back. At the time of the report, the patient was recovering. Additional information has been requested.  9/25/07 Reviewed rheumatologist medical records of 4/10-8/28/2007 which reveal patient experienced alopecia starting approx 2/10/07 after tanning session.  Whe then developed other problems: abnormal thyroid, iron deficiency, nose ulcers, rash on face, neck & hands, worsening pain of wrists & hands, intermittent left knee swelling & pain, pleuritic chest pain, back pain, migraines w/nausea & photophobia since 10/06, dry eyes, diffuse myalgias, paresthesias, 9# weight loss, night sweats, palpitations.  Saw dermatologist & had injections which resulted in some hair loss in other areas. Hair loss continued on subsequent visits becoming more global.  Referred for endocrine evaluation secondary to birth control pills.  6/11/07 developed raw urticarial skin lesions. By 7/19 began to have return patchy hair growth. FINAL DX: alopecia areata universalis.
FELT KIND OF YUCKY; BURNED A LITTLE; MALAISE/DON'T FEEL GOOD; SORE ARM; FELT LIKE ALLERGIES; COLD; FATIGUE/TIRED/FEELING RUN DOWN; SHIVERING/CHILLS; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hip and knee pain arthritis, and other pre-existing medical conditions included consumer took an antidepressant and blood pressure medicine and centrum multivitamin when she could afford it. The patient was previously treated with pneumococcal vaccine, influenza vaccine, and varicella zoster vaccine rge (cho) for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included naproxen for hip and left knee arthritis, and paracetamol for to prevent headaches. On 29-MAR-2021, the subject experienced shivering/chills. On 29-MAR-2021, the subject experienced fatigue/tired/feeling run down. On 30-MAR-2021, the subject experienced cold. On 30-MAR-2021, the subject experienced felt like allergies. On an unspecified date, the subject experienced felt kind of yucky, burned a little, malaise/don't feel good, and sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold, felt kind of yucky, malaise/don't feel good, sore arm, shivering/chills, felt like allergies, and fatigue/tired/feeling run down, and the outcome of burned a little was not reported. This report was non-serious.
No adverse effects; Inadvertently received a third dose of VARIVAX; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapies were not reported.  On 16-OCT-2019, the patient inadvertently received third dose of varicella virus vaccine live (oka/merck) (VARIVAX) (extra dose administered) (strength, dose, route were not reported, lot # S019462 and expiration date 24-JUN-2019) for prophylaxis. No adverse event was reported. No product quality complaint (PQC) was reported.
Information has been received from an RN concerning a 66 year old male pt who on 10/7/99 was vaccinated with a second dose of pneumococcal vaccine 23 polyvalent IM in the right arm and on 10/6/99 included influenza virus vaccine IM in the left arm. It was noted that the pt receives influenza virus vaccine "yearly." On 10/8/99, the pt presented with injection site pain, redness, warmth and swelling and difficulty raising his right arm. No fever was noted. The pt was advised to take Advil and apply ice packs to the involved area. Follow-up information from an RN reported that on 10/11/99, the pt recovered.
About a month after the vaccine, I had a seizure and then I had another one 6 months later. I went to my doctor about this. They did EEG, MRI, and brain CT scan. It did not show anything abnormal. I will be having another EEG scheduled for next week.
Area of injection became red, warm to touch, tender, size is 3 x 3 in. Pt. c/o itching and burning sensation. KEFLEX ordered on 1-14-15-improved by 1-15-15.
Individual with multiple symptoms tested Covid positive on 12/19/21. She will continue to remain isolated until 12/28/21 and callback for follow up. She's still symptomatic  with cough, congestion, and fatigue. Infection control notified.
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Received doses from vials affected by temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Received doses from vials affected by temperature excursion) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049L21A) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Jun-2022 at 9:51 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jun-2022 at 9:51 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Received doses from vials affected by temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Received doses from vials affected by temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Received doses from vials affected by temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Received doses from vials affected by temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. 20 patients received doses from the lot number affected by a temperature excursion as the freezer went out of range. Patient received half dose. It was reported that no adverse event occurred at time of administration or were reported thereafter. Treatment medications were not reported.
Starting that night and then now a few weeks later, not feeling well, then onset of panic attacks daily, multiple times a day
Pt crying-fussy, would not take afternoon nap, would not walk; given APAP, would not eat, woke up crying, lt thigh red & swollen;
1-3 mins after receiving shot I experienced blurry vision and dizziness. Lasted a few minutes then stopped. Afterwards a headache that lasted the rest of the day.
S/p +23 hrs vaccination, patient presented to allergy clinic for routine administration of allergy shots (environmental allergens only). Within appx 90 sec of injections (2 left arm + 1 right arm; blue top; 0.50 uL), patient developed intense SOB and tightness in clinic waiting room. Pt presented to staff to report AE: staff immediately moved pt to private room in clinic. Assessed  vitals and breathing/chest sounds. BP appx 140/88, BP appx 99, normal chest sounds. Repeated q10min x2: BP down appx 5 points each time; final HR appx 92 bpm. D/c?d to home. Throughout, pt lightheaded, dizzy, and disturbed by rapid heart beat/sensation. Symptoms continued s/o d/c except that SOB resolved: pt took #2 puffs albuterol sulfate HFA 90 mcg immediately before reporting to clinic; pt repeated #2 puffs on own volition appx 10 min s/p admission to private room in clinic. Pt monitored for appx 45 min total.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 74-year-old male patient received BNT162b2 (BNT162B2), in Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 74 years for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (MANUFACTURER: UNKNOWN, DOSE 3 (BOOSTER), SINGLE), for Covid-19 Immunization; Covid-19 vaccine (MANUFACTURER: UNKNOWN, DOSE 2, SINGLE), for Covid-19 Immunization; Covid-19 vaccine (MANUFACTURER: UNKNOWN, DOSE 1, SINGLE), for Covid-19 Immunization. The following information was reported: SUPRAVENTRICULAR TACHYCARDIA (non-serious) with onset Jun2022, outcome "unknown", described as "SVT". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller (74-year-old) was a consumer asking if there are reports of SVT after getting 2nd booster shot of Pfizer COVID19 vaccine. Caller added that he got the shot yesterday evening at 5 o clock and has SVT that morning at 7:30.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
ARM SWELLIN TRAVELED BELOW THE ELBOW AND MUSCLE PARALYSIS WITH TEMP OF 99.
This spontaneous report has been received from a consumer of unknown gender (Manufacturer No. 2015BAX021188) referring to him/herself. The patient had not pertinent medical history and there were no drug allergies/drug reactions reported. On an unknown date, the patient was vaccinated with PNEUMOVAX23, (lot number, expiration date, route, dose, strength and anatomical location were not reported). No concomitant medication was reported. On an unknown date, the patient experienced pneumonia. At the reporting time, the outcome of pneumonia was unknown. Additional information has been requested.
On the third day, I had swollen gland in my right side of neck and back of head. It continued for over a week; This is a spontaneous report from a contactable consumer or other non-healthcare professional (reported for herself). A 70-years-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL9269) administered in right arm via an unknown route of administration on 11Feb2021 at 15:45pm as SINGLE DOSE for covid-19 immunization. The patient previously received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL8982) administered in left arm on 21Jan2021 at 03:45pm. The patient medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination. The patient did not have any other vaccine in four weeks and other medications in two weeks. On 14Feb2021 at 09:00 pm (3 days after vaccination), the patient had swollen gland in right side of neck and back of head. It continued for over a week. The outcome of the event was unknown.
Fever of 103, severe body pain, uncontrollable shaking, severe migraine, sore throat, difficulty breathing,  nausea
No noticeable symptoms on the first day.  On day two, the patient experienced swelling and pain in the left arm which evolved into flu-like body aches and pains, as well as a fever not exceeding 101 F.  This continued until day 3 in which symptoms were still present but much improved.
OBSTRUCTIVE SLEEP APNEA 5/27/2022 URINARY RETENTION STABLE ANGINA 2/15/2022 URINARY RETENTION ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 11/23/2021 URINARY RETENTION
her voice feels a little weak; having problems breathing; lot of Phlegm; coughing a lot; fingers started tingling; waves of nausea; light headedness; She started to itch; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN8203 and expiration date 30Aug2021), via an unspecified route of administration in left arm on 01Mar2021 at 14:30 (age at vaccination 60-year-old) as single dose for COVID-19 immunization. Medical history included type 1 diabetes mellitus, hashimoto's disease, high cholesterol and high blood pressure. Concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to covid vaccine. On 01Mar2021, with a few minutes just driving to the waiting spot she was having problems breathing. There was plenty of staff there in the hospital parking lot to help. They were monitoring her oxygen and her heart also on 01Mar20210, patient experienced lot of phlegm, coughing a lot, fingers started tingling, waves of nausea, light headedness and on 03Mar2021, patients voice felt a little weak. She was treated with Benadryl and an inhaler. The outcome of event having problems breathing, fingers started tingling, light headedness, waves of nausea was recovered on 01Mar2021. The outcome of event lot of Phlegm and coughing a lot was recovering at the time of reporting. The outcome of itching and her voice feels a little weak was unknown.  No follow-up attempts are possible. No further information is expected.
Patient with fever measured axillary at home to 105F. Given Motrin or Tylenol and seen at Urgent care. Per mom, fever reduced to ~102F when measured at urgent care
devel dry cough w/in 4 wks coughing was very bad turned blue every cough spasm-excessive mucus-choking-could not catch breath taken to ER;dx w/whooping cough;reflux
Three hours after the vaccine, I developed a fever of 101 degrees. I took Tylenol for at least 36 hours. My arm hurt, I had a headache, I had joint pain, and muscular pain. This is true of the first and second vaccines. I have been following the news on COVID, and I am considered a long-hauler. My sense of smell is affected as is my sense of taste. I still have muscle weakness as well as joint pain and a new symptom: bone pain. After I contracted COVID in December, I noticed that my hair was falling out. Since the two vaccines on March 4 and April 1, my hair is falling out in clumps after shampoos and combing. At this rate, I should be bald by the summer. Thanks alot! I will need a wig soon. Furthermore, I'm not the only one. My Pharmacist is hearing from a lot of people, complaints about their hair falling out. The CDC needs to incorporate this after symptom in their list of symptoms.
Pt recvd 2 doses of Engerix-B & had no reaction p/1st dose; hrs p/2nd dose devel fever of 102, chills, sweating, myalgia, nausea, vomiting, rigors, joint pains, upper abdominal pains & arthralgia; pt was seen by MD;
Tested positive for Covid and they were vaccinated; Tested positive for Covid and they were vaccinated; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 5 patients. This is 2 of 5 reports.  A consumer reported for her daughter of an unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown) on an unknown date at a single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The daughter and son-law were tested positive for Covid the week before reporting and they were vaccinated, except for the kids. The kids can't be vaccinated yet and hopefully this will get approved pretty quickly for the kids. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101427488 same reporter, differet patient
Patient received regular 2 mo. immunizations on 3/19/2007. Mother reported a hx of seizures on vaccine administration questionaire form. Mother reported no illness on the day of vaccination and that child had received Hep. B vaccine at birth with no complications. Child received vaccine between 9am and 11am. Mother reports that approximately 3 hours post immunization, child developed a fever of 102 degrees and did have approximately 6-8 episodes of seizure activity with jerking motions in the infants body. Mom reports ambulance called and infant transported to Hospital and was admitted there x 3 days. Child stable at this time and home with Mom. Child's pediatrician, per Mom, states no further immunizations for child until further notice.  03/28/2007 MR received for a 3 day hospitalization for fever and seizures on the evening of her 2 month vax.  Child felt hot to touch, and had a decreased appetite.  Infant had 6 seizures prior to ER visit.  ER temp was 101.7'F rectally.  PE:  WNL except eyelashes coated with yello-green discharge. Treated with IVF and antibiotics. One brief seizure during hospitalization. Discharge DX:  1) Sepsis ruled out. 2) Seizure disorder. 3)  Dacryostenosis.
Severe allergic reaction developed 8 days after vaccination- severe hives all over body, face with swelling and itching
pt hosp on 21MAR97 p/vax;sx 100.3 temp;white & clammy, vomiting, unconsolable, high pitched cry;hosp from evening of 21MAR97 to morning of 22MAR97 for observation;